{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007071","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.839004+00:00","generated_at":"2026-05-16T23:21:56.037925+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HBIO Q3: revenues $20.6M, net loss narrows to $1.2M; Q4 guidance $22.5-$24.5M","bullets":["Q3 2025 revenues $20.6M (down 6.4% YoY); gross margin 58.4% vs 58.1%.","Net loss ($1.2M) vs ($4.8M) YoY; adjusted EBITDA $2.0M vs $1.3M.","Cash from operations $1.1M positive vs ($0.8M) in Q3 2024.","Company in active discussions to refinance or repay credit agreement in Q4.","Q4 guidance: revenues $22.5M-$24.5M, gross margin 58%-60%; cites increased demand and backlog."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007071","json":"https://secwatch.observer/filing/0001171843-25-007071.json","markdown":"https://secwatch.observer/filing/0001171843-25-007071.md","text":"https://secwatch.observer/filing/0001171843-25-007071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007071/0001171843-25-007071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007071/f8k_110625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:21:56.037925+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}